Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.1810
-0.0086 (-4.54%)
Feb 5, 2026, 5:21 PM CET
-60.65%
Market Cap12.20M -42.8%
Revenue (ttm)n/a
Net Income-8.42M
EPS-0.16
Shares Out64.36M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume191,411
Average Volume223,371
Open0.1898
Previous Close0.1896
Day's Range0.1800 - 0.1898
52-Week Range0.1500 - 0.7000
Beta-0.25
RSI38.69
Earnings DateFeb 20, 2026

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) a clinical pharmaceutical company, developing an injection-based treatments for disc herniation. It develops STA363, an injection into the disc that targets chronic low back and leg pain. The company was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements